Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
以三个月预期寿命作为晚期胰腺癌临床试验的纳入标准:这真的是选择患者的有效工具吗?
期刊:Clinical & Translational Oncology
影响因子:2.5
doi:10.1007/s12094-023-03323-1
Weiss, Lena; Heinemann, Volker; Fischer, Laura E; Gieseler, Frank; Hoehler, Thomas; Mayerle, Julia; Quietzsch, Detlef; Reinacher-Schick, Anke; Schenk, Michael; Seipelt, Gernot; Siveke, Jens T; Stahl, Michael; Vehling-Kaiser, Ursula; Waldschmidt, Dirk T; Dorman, Klara; Zhang, Danmei; Westphalen, C Benedikt; von Bergwelt-Baildon, Michael; Boeck, Stefan; Haas, Michael